Defining the disease course of TNFalpha blockers-associated Multiple Sclerosis. Lucchini M, Giuffre GM, Nociti V, Bianco A, et al. J Neuroimmunol 2021;353:577525.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lucchini M, Giuffre GM, Nociti V, Bianco A, et al. Defining the disease course of TNFalpha blockers-associated Multiple Sclerosis. J Neuroimmunol 2021;353:577525.
PMID: 33647875